Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy

Practice guidelines incorporate genomic tumor profiling, using results such as the Oncotype DX Recurrence Score (RS), to refine recurrence risk estimates for the large proportion of breast cancer patients with early-stage, estrogen receptor-positive disease. We sought to understand the impact of rec...

Full description

Saved in:
Bibliographic Details
Published in:Breast Cancer Res Treat
Main Authors: Evans, Chalanda N., Brewer, Noel T., Vadaparampil, Susan T., Boisvert, Marc, Ottaviano, Yvonne, Lee, M. Catherine, Isaacs, Claudine, Schwartz, Marc D., O’Neill, Suzanne C.
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065914/
https://ncbi.nlm.nih.gov/pubmed/27059031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3780-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items